… s immunopathogenesis response is crucial to determine the disease severity and its clinical
outcome in COVID-19 … -2 transmission dynamics, immunopathogenesis, with the assessment …

… using cytokine blockades, there is insufficient evidence for now demonstrating that using
anticytokine therapies (IL-1β, IL-6, IL-18, and TNF-α) to treat COVID-19 patients is effective (159…

… In this article, the immunopathogenesis of COVID-19 disease, immune modalities to control
… are suggestive of a therapeutic benefit in patients with COVID-19, results of randomized …

… coronavirus (… of COVID-19 on the base of the present understanding of SARS-CoV and
MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic …

… COVID-19 throughout the world is highly threatening, but still, scientists do not have a proper
therapeutic … the world to find effective therapy to combat COVID 19. Several drugs such as …

… From an immunopathogenic viewpoint, COVID-19 disease has probably a … immunopathogenic
model is required to develop future therapeutic approaches in the scenario of COVID-19. …

… This section enumerates the various therapeutic agents along … therapeutic strategies for the
management of COVID-19/… to the therapeutic effects observed in COVID-19 patients.[ 53 55 ] …

… subset has distinct immunopathogenesis, prognosis and … mimics and proceed to early
therapy initiation. The review … to avoid erroneous diagnoses and therapeutic schemes. The main …

… coronavirus-2 causes the coronavirus disease ie, COVID-19. This article encompasses basic
information about coronavirus and COVID-19. It … The immunopathogenesis of COVID-19 is …

… The development of vaccines and therapeutic antibodies against COVID-19 has important
implications. The majority of the vaccines being developed for coronaviruses target the spike …